Holen Sie sich die Stockscreener-App
5.45
1.68%
0.09
Handel nachbörslich:
5.44
-0.010
-0.18%
Schlusskurs vom Vortag:
$5.36
Offen:
$5.34
24-Stunden-Volumen:
60,404
Relative Volume:
1.05
Marktkapitalisierung:
$36.73M
Einnahmen:
$21.23M
Nettoeinkommen (Verlust:
$-72.42M
KGV:
-0.8047
EPS:
-6.7728
Netto-Cashflow:
$-81.69M
1W Leistung:
+1.11%
1M Leistung:
+3.81%
6M Leistung:
+51.39%
1J Leistung:
-46.57%
1-Tages-Spanne:
$5.33
$5.51
1-Wochen-Bereich:
$5.2001
$5.54
52-Wochen-Spanne:
$3.004
$12.50
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Vergleichen Sie GBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GBIO
Generation Bio Co
|
5.45 | 36.12M | 21.23M | -72.42M | -81.69M | -6.7728 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-12-16 | Hochstufung | Wedbush | Neutral → Outperform |
| 2025-08-13 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-10-19 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-24 | Eingeleitet | William Blair | Outperform |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-07-07 | Eingeleitet | Cowen | Outperform |
| 2020-07-07 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-07 | Eingeleitet | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Generation Bio trading resumes - MSN
Generation Bio trading halted, news pending - MSN
Generation Bio stock rating reiterated at Market Perform by Citizens By Investing.com - Investing.com Canada
Generation Bio stock rating reiterated at Market Perform by Citizens - Investing.com Nigeria
Generation Bio (NASDAQ:GBIO) Given a $5.50 Price Target at Wedbush - Defense World
Wedbush Upgrades Generation Bio (GBIO) - Nasdaq
Generation Bio (GBIO) Price Target Increased by 13.40% to 30.94 - MSN
Generation Bio (GBIO) Rating Update: Wedbush Upgrades to Outperf - GuruFocus
NodThera appoints Geoff McDonough, M.D., as independent board member - marketscreener.com
GBIO Downgraded by Jefferies with Price Target Cut by 54.55% | G - GuruFocus
‘Zombie’ biotech buyer Xoma to acquire Generation Bio - BioPharma Dive
Wedbush Upgrades Generation Bio to Outperform From Neutral, Adjusts Price Target to $5.50 From $7 - marketscreener.com
Jefferies Downgrades Generation Bio to Hold From Buy, Adjusts Price Target to $5 From $11 - marketscreener.com
Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria
XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq
XOMA to Acquire Generation Bio (GBIO) in Strategic Merger - GuruFocus
XOMA royalty to acquire Generation Bio - MSN
XOMA Royalty to Acquire Generation Bio - citybiz
The Ademi Firm Investigates Whether Generation Bio Co. Is Obtaining a Fair Price for Its Public Shareholders - 富途牛牛
GBIO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Generation Bio Co. is Fair to Shareholders - The AI Journal
Generation Bio Announces Merger with XOMA Royalty - TipRanks
Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com
Xoma to Acquire Generation Bio (GBIO) for $4.29 Per Share - GuruFocus
XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative
Generation Bio (NASDAQ: GBIO) agrees to XOMA cash plus CVR takeover - Stock Titan
Generation Bio (NASDAQ: GBIO) agrees to $4.29 sale to XOMA Royalty plus CVR - Stock Titan
Generation Bio (GBIO) to be acquired in planned XOMA tender offer - Stock Titan
XOMA Royalty Corporation entered into an agreement to acquire Generation Bio Co. for $28.92 million. - marketscreener.com
Published on: 2025-12-14 17:13:04 - moha.gov.vn
What analysts say about Generation Bio Co stockTechnical Resistance Breaks & Master Stock Selection - earlytimes.in
Is Generation Bio Co. stock gaining market share2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
How Generation Bio Co. stock performs in weak economyJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing - Via TT
Is Generation Bio Co. stock overvalued by current metricsWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
What catalysts could drive Generation Bio Co. stock higherPrice Action & Free Technical Confirmation Trade Alerts - Newser
Generation Bio (GBIO) Stock Analysis Report | Financials & Insights - Benzinga
Here's Why We're A Bit Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation - Yahoo Finance
Layoff Tracker: Valneva Terminates 30 Amid Site Closure - BioSpace
Can Generation Bio Co. stock sustain institutional interest2025 Institutional Moves & Consistent Growth Equity Picks - moha.gov.vn
CEO McDonough Acquires 366 Of Generation Bio Co [GBIO] - TradingView
[Form 4] Generation Bio Co. Insider Trading Activity - Stock Titan
Can Generation Bio Co. stock surprise with earnings upsideMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Will Generation Bio Co. stock deliver consistent dividendsPortfolio Return Report & Long-Term Growth Plans - newser.com
Why Generation Bio Co. stock remains a top recommendationGap Down & Real-Time Stock Entry Alerts - newser.com
Why Generation Bio Co. stock remains resilientWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Using data models to predict Generation Bio Co. stock movement2025 Stock Rankings & Growth Oriented Trading Recommendations - newser.com
Ranking Generation Bio Co. among high performing stocks via toolsWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com
How Generation Bio Co. stock reacts to inflationary pressuresWeekly Stock Analysis & Safe Capital Investment Plans - newser.com
Heatmap analysis for Generation Bio Co. and competitorsPortfolio Value Report & Risk Adjusted Swing Trade Ideas - newser.com
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):